Aminocyclopentane esters and pharmaceutical formulation
US4482549A · kind A · utility
5Cited by
8References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 1984 |
| Grant date | Nov 13, 1984 |
| Priority date | — |
| Expiry date | Feb 8, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds are described of the formula ##STR1## in which --COR.sup.1 is a complex ester or thioester group, PA0 W is alkylene, PA0 X is cis or trans --CH.dbd.CH or --CH.sub.2 CH.sub.2 --, PA0 n is 1 or 2, PA0 Y is a saturated heterocyclic amino group having 5-8 ring members, and PA0 R.sup.2 is unsubstituted or substituted phenylalkyl, thienzlalkyl, naphthylalkyl or cinnamyl, and their salts and solvates. These compounds inhibit blood platelet aggregation and bronchoconstriction and may be formulated for use as antithrombotic and antiasthmatic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.